Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lele Ye

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Immunology|November 5, 2019
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal CancerLele Ye, Teming Zhang, Zhengchun Kang, et al.
Pharmacological Research|June 24, 2024
RNA epigenetic modifications in digestive tract cancers: Friends or foesZekai Nian, Ming Deng, Lele Ye, et al.
Frontiers in Immunology|May 19, 2022
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian CarcinomaLele Ye, Kan Pan, Su Fang, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Frontiers in Immunology|November 5, 2019
Tumor-Infiltrating Immune Cells Act as a Marker for Prognosis in Colorectal CancerLele Ye, Teming Zhang, Zhengchun Kang, et al.
Pharmacological Research|June 24, 2024
RNA epigenetic modifications in digestive tract cancers: Friends or foesZekai Nian, Ming Deng, Lele Ye, et al.
Frontiers in Immunology|May 19, 2022
Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian CarcinomaLele Ye, Kan Pan, Su Fang, et al.
Pageof 4